Neurology
AKT · Neurology/Infection & structurallow yield

Vestibular schwannoma (acoustic neuroma)

Benign Schwann-cell tumour of CN VIII at the cerebellopontine angle

Overview

A benign tumour of the vestibulocochlear nerve’s Schwann cells at the cerebellopontine angle. The classic presentation is UNILATERAL sensorineural hearing loss with tinnitus; as it grows it affects adjacent cranial nerves (V, VII). Bilateral tumours suggest neurofibromatosis type 2.

Recognise

  • Unilateral sensorineural hearing loss + tinnitus (the key early features) ± vertigo/imbalance
  • Larger: facial numbness (CN V, absent corneal reflex), facial weakness (CN VII), cerebellar signs
  • Bilateral vestibular schwannomas = neurofibromatosis type 2

Red flags

  • Any asymmetric/unilateral sensorineural hearing loss → MRI to exclude this; brainstem compression if large

Differentials & how to tell them apart

Ménière diseaseepisodic vertigo + fluctuating hearing loss + tinnitus + aural fullness, no CPA mass
Other cerebellopontine-angle tumour (meningioma)imaging characteristics
Presbycusissymmetrical age-related loss
Sudden sensorineural hearing lossacute, often idiopathic/vascular

Investigations

MRI of the internal auditory meatus/cerebellopontine angle (the diagnostic test); pure-tone audiometry (asymmetric sensorineural loss).

Management

MRI to diagnose; manage by size — observe, microsurgery, or stereotactic radiosurgery

  1. 1Asymmetric sensorineural hearing loss → MRI of the cerebellopontine angle. Manage by size/growth/symptoms: serial observation, stereotactic radiosurgery, or microsurgical excision.Gate: Any UNILATERAL/asymmetric sensorineural hearing loss should be imaged (MRI) to exclude a vestibular schwannoma — do not attribute it to age
  2. 2Bilateral tumours → investigate for neurofibromatosis type 2 (genetics); monitor facial-nerve function with treatment.
No drug — observation/surgery/radiosurgerymanagement is by size/growth, not medication

Key points

Unilateral sensorineural hearing loss + tinnitus = image the CPA. Bilateral = NF2. Distinguish from Ménière (episodic vertigo + aural fullness, no mass).

Monitor & prognosis

Hearing, facial-nerve function, tumour growth on serial MRI.

Benign and slow-growing; good outcomes with timely treatment.

Source: NICE CKS (hearing loss); ENT/neurosurgery